eFFECTOR Therapeutics to Participate in The JMP Securities Hematology and Oncology Summit

NEXT STORY
Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits
PREV STORY
FINN Partners Expands its Omni-Channel Communications Capabilities with Addition of Pharmacy Podcast Network
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UAB and Mereo Announce Positive Top-line Results from “COSTA” a Phase 1b/2 Trial of Alvelestat (MPH966) in Hospitalized Patients with COVID-19 Respiratory Disease

author_avatar
NASDAQ Market News

Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development

author_avatar
NASDAQ Market News

Sen-Jam Pharmaceutical Reports the Positive Effect of Payer Options and Expanded Coverage for Individuals with Opioid Use Disorder

HUNTINGTON, N.Y., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Opioid Epidemic is an incredibly ...

author_avatar
NASDAQ Market News